Ersilia is a nonprofit organisation that supports research for infectious and neglected diseases. Our goal is to facilitate adoption of artificial intelligence tools to accelerate the development of new medicines. We focus on establishing collaborations in low-resourced settings where the costs of drug discovery are prohibitive.
We are on a mission to make scientific progress accessible to all
Ersilia Open Source Initiative is registered with the Charity Commission for England and Wales
We want to democratise drug discovery by providing a friendly and transparent resource available to everyone.
We empower research where medical care is most needed by fostering collaborations with health organizations in low- and middle-income countries.
We illuminate neglected regions of the chemical space to enable drug repurposing, hit-to-lead optimisation and generation of new molecules.
Researchers interested in a specific disease, target or pathogen can use our tools to prioritize drug candidates. The way around is also true. Given a drug of interest, Ersilia will scope for potential indications, mechanisms of action or toxicities.
Increase the visibility of existing methods
We collect and deploy AI/ML models currently scattered in scientific papers, code repositories and supplementary materials.
Exploit results of drug screening campaigns
We search the scientific literature for relevant experimental datasets and use them to train our own AI/ML models.
Foster in-country research
We actively seek collaborators working in infectious and neglected diseases to jointly develop customised tools.
Emphasis on local resources
We leverage the potential of natural products to identify new chemical leads for endemic diseases.
Building the Ersilia Model Hub
We are assembling the largest collection of ready-to-use AI/ML models for drug discovery.